Issue: April 2009
April 01, 2009
1 min read
Save

S. aureus cultured from nares did not match wound isolates in many children with skin infections

Issue: April 2009
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Discordance between Staphylococcus aureus isolates cultured from nasal and wound sites and discrepancies between nasal colonization status and incidence of recurrent infections among children suggests that nasal colonization may not be an accurate marker for predicting which children are at risk for recurrent community-associated methicillin-resistant Staphylococcus aureus skin infections.

Researchers from Johns Hopkins Medical Institute obtained cultures from 95 children, 93% of whom were black, with skin and soft tissue infections participating in a trial conducted to compare cephalexin and clindamycin as outpatient treatments.

MRSA was isolated from the wounds of 83 patients and from the nares of 40 patients. S. aureus was isolated from both wound and nasal cultures in 39 patients, but only 23 had isolates with identical methicillin susceptibility and pulsed field gel electrophoresis type from both sites. “A striking 33% of our patients either grew MRSA from their wound but methicillin-susceptible S. aureus from their nose or MSSA from their wound but MRSA from their nose,” the researchers wrote.

Furthermore, patients with MRSA isolates obtained from nasal culture after initial skin infection had a 19% recurrence risk compared with the 42% recurrence risk observed in patients without MRSA-positive nasal cultures.

Chen AE. Pediatr Infect Dis J. 2009;doi:10.1097/INF.0b013e31818cb0c4.

PERSPECTIVE

This is a small study involving mostly black children from a limited geographic area. A lot more work still needs to be done in different settings, because there are clearly differences in different geographic areas and even within the same city. With the percentage of MRSA we’re isolating in three different hospitals here in New Orleans, there’s a difference of up to 40% between two of the hospitals.

This study shows that patients are getting recurrences of MRSA infections from sources other than the nose, which we knew anyway because risk factors include close body contact with people that are infected, contaminated fomites or sports equipment. We should use caution in our interpretation until there are more data.

George A. Pankey, MD

Infectious Disease News Editorial Board member